In brief: Resmed’s sleep survey, AOM Infusion’s distinction, McKesson’s new CFO

SAN DIEGO – While 53% of respondents rank sleep as the most important contributor to long-term health compared to diet and exercise, many are not taking meaningful steps to improve their sleep quality, according to Resmed’s sixth annual Global Sleep Survey.

Sleep is increasingly recognized as a key pillar of long-term health, with 84% of respondents worldwide understanding that consistent, quality sleep can help extend a healthy lifespan. However, awareness has not translated into consistent results. The majority of respondents (53%) report getting a good night’s sleep only four nights a week or fewer, highlighting the persistent gap between knowing sleep is critical and being able to prioritize it as part of a healthy lifestyle.

“People are increasingly recognizing sleep as a cornerstone to long-term health, which is encouraging,” said Dr. Carlos Nunez, chief medical officer at Resmed. “But recognition alone is not enough. We need to help people move from awareness to action by addressing everyday barriers and improving access to screening, support and care.”

Resmed commissioned the independent survey of 30,000 individuals across the United States and 12 other markets.

As sleep awareness grows, so does the opportunity to turn intent into action, the survey found:

• Increased wearable use raises sleep awareness higher than ever: Wearable use for sleep tracking has surged among respondents, increasing from 16% in 2025 to 53% in 2026. Smartwatches lead the way, with 58% of respondents globally using them to track their sleep. Among wearable users, 62% say they would seek medical advice if their device flagged a potential risk.
• Following through on healthcare provider conversations remains a challenge: While 66% of respondents say they would consult a healthcare provider for persistent sleep issues, only 23% have done so. Fewer than half (46%) of survey respondents say a healthcare provider has asked about sleep during a routine visit.

Resmed says the findings suggest a clear opportunity to improve education, screening and diagnosis so more people can identify sleep issues earlier and access pathways to care.

The survey also highlights the everyday pressures shaping sleep patterns worldwide:

• Closing the sleep gap for women: Nearly half of women surveyed (48%) struggle to fall asleep, up from 38% in 2025.2 For 42% of women surveyed, stress and anxiety are key barriers to consistent, quality sleep compared with over one third (36%) of men surveyed. Family responsibilities widen the gender gap further, negatively affecting sleep for 39% of women versus 33% of men.
• Recognizing sleep as a mental health essential: Insufficient sleep is linked to higher risk of anxiety and depression across age groups. This is reflected in our survey, which shows after a poor night’s sleep, more than a third of respondents report higher levels of irritability (36%) and stress (33%). Feelings of depression also increased for a quarter of respondents globally (25%).
• Making sleep a workplace priority: More than half of respondents (58%) agree that heavy workloads negatively affect their sleep. 70% of respondents report taking a “snooze day” — calling in sick after a poor night’s sleep. At the same time, 59% say flexible working arrangements help them better manage their sleep.
• Improving sleep in shared spaces: Sleeping together is associated with stronger intimacy, with 53% of respondents reporting a positive impact on their sex life compared to 23% of those who sleep apart. However, disruption is common: 39% of respondents say their partner interrupts their sleep at least weekly, and 80% experience some level of partner-related sleep disruption.

McKesson announces CFO transition amid spin off of Medical Surgical business

IRVING, Texas – McKesson has announced that Britt Vitalone, executive vice president and CFO, has elected to retire after a 20-year career with the company, including more than eight years as CFO. He will be replaced by Kenny Cheung effective May 29. “Britt is an exceptional partner and leader,” said Brian Tyler, CEO. “He has been instrumental in advancing the company’s financial performance, engaging with shareholders, and instilling a culture of financial discipline. He has consistently emphasized aligning strategy with execution. His financial stewardship and disciplined approach to capital allocation have driven meaningful value creation and helped strengthen our financial foundation and evolve our portfolio to position McKesson for long-term success. I’m deeply grateful for his leadership and the impact it has had on the company.” Vitalone will continue to work with McKesson as a strategic advisor to support a smooth transition and the planned separation of the company’s Medical Surgical Solutions business. Cheung joins McKesson from Sysco, where he served as executive vice president and CFO, overseeing global financial planning and analysis, accounting, audit, tax, and corporate finance.

Medline prices secondary offering

NORTHFIELD, Ill. – Medline has announced the pricing of a previously announced secondary offering of 75,000,000 shares of Medline Inc.’s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., The Carlyle Group Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the “Selling Stockholders”) at a price to the public of $41.00 per share. The selling stockholders have also granted the underwriters a 30-day option to purchase up to an additional 11,250,000 shares of Medline’s Class A common stock. The offering is expected to close on March 10, 2026, subject to customary closing conditions. Medline is not selling any shares of Class A common stock in the offering and will not receive any of the proceeds from the sale. The company closed its upside initial public offering (IPO) in December.

Medline highlights top-performing distribution centers

NORTHFIELD, Ill. – Medline has announced the recipients of its Distribution Center of the Year Award and Safety, Awareness for Everyone (SAFE) Award to its top-performing facilities. These awards are given to the top-performing Medline distribution centers in the United States across its four tiers of size, as determined by the sales volume distributed out of each facility.

2025 SAFE Award Recipients

• Tier 1: Katy, Texas
• Tier 2: Mebane, N.C.
• Tier 3: Richmond, Va.
• Tier 4: Lincolnton, N.C.

2025 Distribution Center of the Year Award Recipients

• Tier 1: Rialto, Calif.
• Tier 2: Southaven, Miss.
• Tier 3: Richmond, Va.
• Tier 4: Medley, Fla.

“Medline’s ability to provide next-day delivery to 95% of our U.S. customers is attributable to the dedication of our team members, who consistently strive to improve healthcare operations,” said Sean Halligan, executive vice president of supply chain. “These awards recognize our teams for their commitment to safety, diligent work and ongoing efforts to meet the needs of healthcare providers across the nation. Medline team members who work at these facilities take pride in knowing they are providing the highest-quality consistent, reliable and safe service to the company’s healthcare customers.”

For the Distribution Center of the Year Award, each facility is graded using objective criteria across multiple categories, including safety, service, quality, cost and people. For the SAFE Awards, facilities are judged based on a scorecard that accounts for a variety of metrics, with the number of recordable safety incidents being the most influential.

Medline has been providing these awards to its highest-performing locations for more than 20 years.

AOM becomes ‘early adopter’ with new Ig therapy distinction

ARLINGTON, Texas – AOM Infusion (AOM) has earned the Distinction in Immunoglobulin (Ig) Therapy from the Accreditation Commission for Health Care (ACHC) in collaboration with the Immunoglobulin National Society (IgNS). This distinction is designed to identify immunoglobulin therapy centers of excellence, and AOM is proud to be among the first infusion therapy providers nationwide to receive it, the company says. “This distinction reflects the work we do every day to improve health and enhance lives through clinically rigorous, patient-centered infusion care,” says John Vlahopoulos, chief clinical officer at AOM Infusion. “We pursued the Ig Distinction to align our immunoglobulin therapy program with the most comprehensive standards of practice, ensuring the highest quality care for our patients. This recognition underscores our ongoing commitment to clinical excellence, outcomes, and patient education.” To earn the Ig Distinction, providers must already hold ACHC Specialty Pharmacy Accreditation or ACHC Infusion Pharmacy Accreditation and demonstrate adherence to an extensive set of clinical, operational, and professional standards. These standards evaluate every aspect of a provider’s immunoglobulin program, including policies for patient acceptance, care planning, and ethical oversight, as well as continuous monitoring of program effectiveness using data to guide care decisions and improve outcomes. “The Distinction in Ig Therapy was created to elevate immunoglobulin therapy nationwide by recognizing infusion therapy providers that go beyond baseline accreditation and truly demonstrate their expertise,” says Caroline Girardeau, PharmD, ACHC’s Pharmacy Accreditation Program director. “AOM Infusion was an early adopter, participating in a beta-survey to field test our standards for relevance. This serves to set a new benchmark in immunoglobulin therapy, demonstrating excellence in clinical care, patient education, and training. We are proud to recognize AOM as one of the first providers to earn this distinction.”

Sequel Med Tech’s twiist now available nationwide

MANCHESTER, N.H. – Sequel Med Tech has announced broad national availability of its twist Automated Insulin Delivery (AID) System powered by Tidepool, following clearance by the U.S. Food and Drug Administration in 2024 and a subsequent controlled launch. “With twiist now accessible to more people than ever before, we’ve reached a meaningful milestone for Sequel and for people living with type 1 diabetes,” said Sequel CEO and Co-Founder Alan Lotvin, MD. “twiist was built to fit into real life, combining precise insulin delivery, an advanced algorithm, and a user experience shaped by the lived experience of people with diabetes. The result is automated insulin delivery designed to deliver the benefits of automation with precision while creating greater personalization and choice.” Built on Sequel’s proprietary iiSure Technology, twiist enables earlier detection of delivery issues, alerting users to blockages up to nine times faster than other AID systems, potentially reducing the risk of unexplained high glucose and giving users the time to take action before experiencing severe high blood sugar or DKA2. Cleared for people ages six and older with Type 1 diabetes, the system is designed to adjust basal insulin to individual dosing needs while offering personalization features that let people manage their diabetes in a way that fits their lives. It is powered by the twiist Loop algorithm, based on the community-developed Tidepool Loop, enabling the system to automatically adjust basal insulin delivery based on continuous glucose monitor (CGM) readings, personalized settings and predicted glucose levels.

Fraud roundup: Three individuals sentenced in brace-related schemes

BOSTON – A Geneva, Ill., man has been sentenced in a Boston federal court to two years in prison for a fraud scheme to defraud Medicare of more than $2 million by submitting claims for durable medical equipment (DME) that was medically unnecessary, not wanted by the Medicare beneficiaries and tainted by kickbacks. In August 2025, Kartik Bhatia, 36, was charged with one count of conspiracy to commit health care fraud and one count of making false statements. According to the U.S. Attorney’s Office for the District of Massachusetts, Bhatia worked with Raju Sharma, and other co-conspirators to own and operate a DME company that paid telemarketing companies for DME orders for orthotics such as ankle, wrist, knee and back braces. After CMS issued a payment suspension to Bhatia’s DME company, Bhatia simply opened a new DME company that engaged in the same conduct.

FULSHEAR, Texas – A Texas man has been sentenced to 90 months in prison for his role in a $59.9 million conspiracy to pay kickbacks and submit claims for medically unnecessary DME to Medicare. According to court documents, Patrick Cassells, 65, of Fulshear, owned and operated three DME companies and concealed his role in one of those companies by falsely identifying another individual as the sole owner and manager in a Medicare enrollment application. Cassells paid illegal kickbacks to co-conspirators who sent him signed doctor orders and other paperwork necessary to bill Medicare for orthotic braces such as knee, back, shoulder and wrist braces. The kickbacks were disguised by referring to the doctor orders as “leads” and the services provided as “marketing.” Based on these orders, which were issued without doctors examining or treating the patients, Cassells submitted claims to Medicare that falsely represented that the braces were medically necessary. In total, through the three companies, Cassells caused more than $59.9 million in false and fraudulent claims to Medicare, for which Medicare paid over $27 million. Cassells used proceeds of the fraud to purchase personal vehicles and vehicles that he intended to export to Nigeria. In June 2024, Cassells pleaded guilty in the Southern District of Texas to one count of conspiracy to commit health care fraud. In addition to the prison sentence, Cassells was ordered to pay $25,402,614.97 in restitution and forfeiture, and to forfeit four vehicles and three properties in the Houston area.

NEWARK, N.J. – A Georgia chiropractor was sentenced to 43 months in prison for her role in a $14.9 million health care fraud and illegal kickback conspiracy. Teflyon Cameron, 59, of Powder Springs, Ga., previously pleaded guilty before U.S. District Judge Michael E. Farbiarz on March 2, 2026, in Newark federal court to a charge of conspiracy to commit health care fraud and conspiracy to violate the Federal Anti-Kickback statute. According to documents filed in this case and statements made in court:

• For several years, Cameron conspired to defraud health insurers, including Medicare, by causing the submission of claims for medically unnecessary Durable Medical Equipment (DME) and Cancer Genetic Tests (CGx).  In total, Cameron and her conspirators caused a loss to Medicare of more than $14.9 million, and Cameron pocketed more than $1.3 million in fraud proceeds.
• Cameron and her conspirators owned, operated and had a financial interest in DME companies through which they obtained doctor orders for DME, namely orthotic braces, for Medicare beneficiaries without regard to medical necessity. Cameron and her conspirators obtained DME orders using marketing call centers and telemedicine companies, caused the submission of false and fraudulent claims to Medicare, and paid illegal kickbacks.
• Cameron and her conspirators also owned, operated, and had a financial interest in a CGx company through which she agreed to provide a clinical laboratory with leads of beneficiaries who were qualified to receive federal health care benefits for cancer genetic tests. Cameron submitted invoices to the clinical laboratory seeking payment on a per-lead basis, but entered into a sham agreement to disguise kickback and bribe payments.

Healogics taps John Landino to lead growth strategy

JACKSONVILLE, Fla. – Healogics has appointed John P. Landino as chief development officer to lead the company’s growth strategy, expanding new partnerships and business opportunities to advance its mission. Landino brings nearly 20 years of experience in business development, marked by a proven ability to forge strategic partnerships with hospital executives and health care leaders, supporting rapid and sustainable organizational growth. "John's extensive experience in health care development and his innovative approach make him an ideal leader for our growth initiatives," said Pamela Mandel, chairman and CEO. "We are thrilled to welcome him to our executive team, and we look forward to working together as we continue to strengthen our partnerships and expand access to advanced wound care in more communities." Landino has held key leadership roles at Fresenius Medical Care North America and Tenet Healthcare, where he helped drive business expansion and physician engagement initiatives.

Motion announces lineup for this year’s Rehab Expo

TORONTO – Motion will once again host the Motion Rehab Expo in 2026, with 10 events scheduled across Alberta, British Columbia, and Ontario. This year, the company will host an event in Sault Ste. Marie, Ontario, for the first time. The complete event schedule:

• Edmonton, AB, April 21
• Calgary, AB, April 23
• GTA, ON, May 5
• Thunder Bay, June 3
• Sault Ste. Marie, June 10
• Courtenay, BC, Sept. 22
• Nanaimo, BC, Sept. 23
• Victoria, BC, Sept. 24
• London, ON, Oct. 21
• Hamilton, ON, Nov. 4

Motion Rehab Expo is a complementary education and networking event for Canadian health care and industry professionals, including therapists, long-term care administrators, funding providers and others. Attendees can expect 15- or 30-minute round robin presentations from equipment manufacturers for both adult and pediatric solutions, as well as the opportunity to trial and review the latest rehab mobility, seating and home accessibility products. Motion is accredited by the International Accreditors for Continuing Education and Training (IACET). Motion merged with Numotion in 2025.

Medline inks supply agreement with Better Life Medical

NORTHFIELD, Ill. – Medline has signed a new supply agreement with Better Life Medical & Surgical Supply, a home medical equipment (HME) provider in Hallandale Beach, Fla. With this agreement, Better Life Medical & Surgical Supply will have access to Medline’s comprehensive portfolio of medical-surgical products, including durable medical equipment (DME) and wound care and urology products, as well as distribution capabilities to help streamline ordering to receive more timely, reliable delivery of medical supplies, Medline says. “At Better Life Medical & Surgical Supply, our mission is to deliver better outcomes for patients and providers across Florida,” said Sam Muminov, president and CEO. “Partnering with Medline gives us the quality, reliability and supply continuity we need to help ensure next-day delivery, prevent discharge delays and support our partners statewide. Together, we are raising the standard for home medical equipment distribution.” Better Life Medical & Surgical Supply also will use the Medline Home Direct program, leveraging Medline’s ability to delivery next day to 95% of U.S. customers.

• Related: Medline boasts $2.4B in new customer signings in 2025.

Short takes: Quipt Home Medical, Sanford Health

Cincinnati, Ohio-based Quipt Home Medical expects to close on its sale to Kingswood Capital Management and Forager Capital Management on March 16, 2026. The company announced on March 5 that the Supreme Court of British Columbia issued a final order related to the sale, paving the way for the close, assuming all other terms and conditions are satisfied. Quipt Home Medical announced late last year that it had agreed to a buy out by a special-purpose acquisition vehicle (SPAC) funded by the two investment firms.

Sanford Health Equip now has a location in Dickson, N.D. The location, adjacent to Sanford Health Occupational Medicine, offers a wide range of products – from CPAP products to urological supplies to wheelchairs. Sanford Health Equip was formed by the merger of Sanford Healthcare Accessories and Sanford Home Medical Equipment. It has 30 locations in hour states.

Reliable Medical adds two execs to board

FRANKLIN, Tenn. – Reliable Medical has appointed John Bertone and Arvind Ramakrishnan to its board of directors. “We are incredibly excited about the impact John and Arvind will have as we execute on our long-term vision,” said Charles Sargeant, CEO of Reliable Medical. “Their passion for the people we serve, depth of industry experience, and strategic insight will be invaluable as we continue building a market-leading organization focused on patients, our people, and sustainable growth.”

John Bertone

Bertone brings more than 35 years of leadership experience in the health care and medical equipment sectors, with a deep focus on complex rehab technology (CRT). He previously held senior leadership roles at National Seating & Mobility (NSM), where he helped scale the organization into a market leader. “I’ve spent my career in CRT because I believe in the difference this technology makes in people’s lives,” he said. “I’m excited to bring that perspective to Reliable Medical as the company enters its next chapter of growth.”

Arvind Ramakrishnan

Ramakrishnan joins the board with a strong background in revenue cycle management (RCM) and health care operations. He has held senior leadership roles at several leading RCM and health technology organizations, including Conifer Health Solutions, R1 RCM and Datavant. He most recently served as CEO of Knack RCM. “I’m honored to join the board and contribute to the important work ahead,” he said. “There is a meaningful opportunity to pair Reliable Medical’s best-in-class clinical platform with more intelligent and efficient revenue cycle operations to drive stronger outcomes for both patients and the business.”

• Related: Reliable Medical to expand CRT reach, modernize systems with Gauge Capital.

Kinex Medical Company agrees to pay $6.9M settlement

MILWAUKEE – Kinex Medical Company has agreed to pay $6.9 million to resolve allegations that it violated the False Claims Act by submitting false claims to Medicare, TRICARE, and other federal programs, according to the U.S. Attorney for the Eastern District of Wisconsin. Based in Waukesha, Wis., Kinex sells and distributes durable medical equipment (DME), including knee, shoulder, and hip braces, to patients across the United States. After receiving information from a whistleblower, the United States investigated and alleged that from 2019 through 2024, Kinex provided patients with medical braces that the patients did not need and then billed Medicare, TRICARE, FEHBP, and OWCP as if the braces had been necessary. The United States also alleged that Kinex convinced the patients to accept the braces by waiving costs like patient co-pays and by giving the patients other equipment for free. Kinex has also entered into a Corporate Integrity Agreement with the U.S. Department of Health and Human Services, Office of the Inspector General (HHS-OIG), to ensure compliance with applicable regulations going forward. The settlement states allegations only; Kinex does not admit liability for the allegations.

Rehasense, UpRiser and SleepRes win product awards at Medtrade

PHOENIX – Rehasense earned the Providers’ Choice Gold Award for its PAWS Power Assist, a line of motorized add-ons for manual wheelchairs, at Medtrade on March 4. The Provider’s Choice Silver award went to the UpRiser, a streamlined electric toilet assist that slides over any porcelain toilet bowl and allows for easy installation. UpRiser is made by Vital Fjord in The Netherlands. The Provider’s Choice Bronze award went to sleep tech innovator SleepRes for its new product, Kricket PAP, which uses the newly developed Kairos Positive Airway Pressure (KPAP) to treat obstructive sleep apnea. The Providers’ Choice Awards are sponsored by HomeCare Magazine.